Dova Pharmaceuticals: 2Q Earnings Snapshot
DURHAM, N.C. (AP) _ Dova Pharmaceuticals Inc. (DOVA) on Thursday reported a loss of $19.7 million in its second quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 70 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.
The pharmaceutical company posted revenue of $4.6 million in the period.
Dova Pharmaceuticals shares have decreased 22 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $22.56, a rise of 21 percent in the last 12 months.